MedEquities Realty Trust (NYSE:MRT) was downgraded by equities research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday.

A number of other equities analysts have also weighed in on the company. Citigroup lowered MedEquities Realty Trust from a “neutral” rating to a “sell” rating and decreased their price target for the company from $10.00 to $9.00 in a research report on Friday. Canaccord Genuity decreased their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, August 9th. B. Riley set a $12.00 price target on MedEquities Realty Trust and gave the company a “buy” rating in a research report on Thursday, August 9th. Zacks Investment Research lowered MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research report on Saturday, August 11th. Finally, KeyCorp lowered MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price target for the company. in a research report on Wednesday, August 8th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the stock. MedEquities Realty Trust currently has an average rating of “Hold” and a consensus target price of $12.00.

MRT stock traded down $0.45 during trading hours on Friday, hitting $9.66. 475,000 shares of the stock traded hands, compared to its average volume of 150,520. MedEquities Realty Trust has a one year low of $9.46 and a one year high of $12.05. The stock has a market capitalization of $328.50 million, a P/E ratio of 8.47 and a beta of -0.16.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.20). MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. The company had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. sell-side analysts expect that MedEquities Realty Trust will post 1.18 EPS for the current year.

Several large investors have recently added to or reduced their stakes in the stock. LSV Asset Management boosted its position in MedEquities Realty Trust by 473.7% during the 1st quarter. LSV Asset Management now owns 53,000 shares of the financial services provider’s stock worth $557,000 after acquiring an additional 43,762 shares during the period. Teachers Insurance & Annuity Association of America boosted its position in MedEquities Realty Trust by 26.5% during the 1st quarter. Teachers Insurance & Annuity Association of America now owns 37,703 shares of the financial services provider’s stock worth $396,000 after acquiring an additional 7,903 shares during the period. Eagle Boston Investment Management Inc. boosted its position in MedEquities Realty Trust by 2.2% during the 1st quarter. Eagle Boston Investment Management Inc. now owns 749,027 shares of the financial services provider’s stock worth $7,872,000 after acquiring an additional 16,363 shares during the period. JPMorgan Chase & Co. boosted its position in MedEquities Realty Trust by 221.9% during the 1st quarter. JPMorgan Chase & Co. now owns 19,898 shares of the financial services provider’s stock worth $210,000 after acquiring an additional 13,717 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in MedEquities Realty Trust by 143.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 74,932 shares of the financial services provider’s stock worth $787,000 after acquiring an additional 44,097 shares during the period. Institutional investors and hedge funds own 90.80% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: Market Capitalization

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.